MYFORTIC vs ZINBRYTA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 17, 2026·How we rate

Possible drug interaction. MYFORTIC and ZINBRYTA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	MYFORTIC	ZINBRYTA
Rating	70/100	New
Pharmacy pays	$0.27 /mL	—
Type	RX	RX
Active ingredient	MYCOPHENOLATE SODIUM	DACLIZUMAB
Manufacturer	Novartis	Biogen
Dosage forms	Tablet, delayed release	Injectable
Drug class	Antimetabolite Immunosuppressant	—
Boxed warning	Boxed warning	None
Treats	Graft Vs Host Disease	Graft Vs Host Disease, Multiple Sclerosis

myfortic zinbryta

Rating

70/100

New

Pharmacy pays

$0.27 /mL

—

Type

Active ingredient

MYCOPHENOLATE SODIUM

DACLIZUMAB

Manufacturer

Novartis

Biogen

Dosage forms

Tablet, delayed release

Injectable

Drug class

Antimetabolite Immunosuppressant

—

Boxed warning

None

Treats

Graft Vs Host Disease

Graft Vs Host Disease, Multiple Sclerosis

Frequently asked questions

What is the difference between Myfortic and Zinbryta?

Myfortic contains Mycophenolate Sodium, while Zinbryta contains Daclizumab — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.